ApoB is a protein component of atherogenic lipoproteins (VLDL, IDL, LDL, Lp(a)) and primarily reflects cardiovascular risk. It is not a direct measure of blood sugar; for that, fasting glucose, HbA1c, or an oral glucose tolerance test are appropriate. However, there is an indirect link: in insulin resistance and type 2 diabetes, the number of small, dense LDL particles often increases, which can elevate ApoB levels. Studies indicate that ApoB is frequently elevated in individuals with metabolic syndrome and may be a better predictor of cardiovascular events than LDL-C. Nonetheless, ApoB does not replace blood glucose testing. For assessing glucose metabolism, fasting glucose, HbA1c, and an OGTT remain the gold standards. An elevated ApoB can signal increased cardiovascular risk in the presence of glucose dysregulation. Evidence is moderate (human-observational), not from randomized trials on glycemic control. Caveat: interpretation without medical context is not advisable.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-3d2d105a18e873d438f80975